investigations of the prevalence of anti-hbc igm in different groups of patients with chronic hepatitis b infection showed 89.4 % anti-hbc igm-positive results in patients with chronic active hepatitis b , 60 % in patients with hbsag-negative chronic active hepatitis , 58.2 % in patients with primary liver carcinoma and markers of hepatitis b infections , and 34.9 % in healthy carriers of hbsag .
C0524909
chronic hepatitis b
C0019163
hepatitis b infections